172 related articles for article (PubMed ID: 14742567)
21. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
22. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.
Linton D; Karlyshev AV; Hitchen PG; Morris HR; Dell A; Gregson NA; Wren BW
Mol Microbiol; 2000 Mar; 35(5):1120-34. PubMed ID: 10712693
[TBL] [Abstract][Full Text] [Related]
23. Comparison of lipooligosaccharide biosynthesis genes of Campylobacter jejuni strains with varying abilities to colonize the chicken gut and to invade Caco-2 cells.
Müller J; Meyer B; Hänel I; Hotzel H
J Med Microbiol; 2007 Dec; 56(Pt 12):1589-1594. PubMed ID: 18033824
[TBL] [Abstract][Full Text] [Related]
24. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
25. Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.
Zhang M; He L; Li Q; Sun H; Gu Y; You Y; Meng F; Zhang J
PLoS One; 2010 Nov; 5(11):e15060. PubMed ID: 21124772
[TBL] [Abstract][Full Text] [Related]
26. Mutation of waaC, encoding heptosyltransferase I in Campylobacter jejuni 81-176, affects the structure of both lipooligosaccharide and capsular carbohydrate.
Kanipes MI; Papp-Szabo E; Guerry P; Monteiro MA
J Bacteriol; 2006 May; 188(9):3273-9. PubMed ID: 16621820
[TBL] [Abstract][Full Text] [Related]
27. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
28. The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168.
St Michael F; Szymanski CM; Li J; Chan KH; Khieu NH; Larocque S; Wakarchuk WW; Brisson JR; Monteiro MA
Eur J Biochem; 2002 Nov; 269(21):5119-36. PubMed ID: 12392544
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
30. An Updated Classification System and Review of the Lipooligosaccharide Biosynthesis Gene Locus in
Hameed A; Woodacre A; Machado LR; Marsden GL
Front Microbiol; 2020; 11():677. PubMed ID: 32508756
[TBL] [Abstract][Full Text] [Related]
31. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
Hye JB; Nachamkin I
Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
[No Abstract] [Full Text] [Related]
32. DNA diversity of the wla gene cluster among serotype HS:19 and non-HS:19 Campylobacter jejuni strains.
Misawa N; Kawashima K; Kondo F; Allos BM; Blaser MJ
J Endotoxin Res; 2001; 7(5):349-58. PubMed ID: 11753203
[TBL] [Abstract][Full Text] [Related]
33. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
Neisser A; Schwerer B; Bernheimer H; Moran AP
J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
[TBL] [Abstract][Full Text] [Related]
34. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
[TBL] [Abstract][Full Text] [Related]
35. Identification of Campylobacter jejuni ATCC 43431-specific genes by whole microbial genome comparisons.
Poly F; Threadgill D; Stintzi A
J Bacteriol; 2004 Jul; 186(14):4781-95. PubMed ID: 15231810
[TBL] [Abstract][Full Text] [Related]
36. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
[TBL] [Abstract][Full Text] [Related]
37. Axonal degeneration induced by intraneural injection of Campylobacter jejuni antiserum containing high titer anti-GM1 antibody.
Shu XM; Cai FC; Zhang XP
Neuropediatrics; 2007 Oct; 38(5):228-32. PubMed ID: 18330836
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Campylobacter jejuni capsular loci reveals multiple mechanisms for the generation of structural diversity and the ability to form complex heptoses.
Karlyshev AV; Champion OL; Churcher C; Brisson JR; Jarrell HC; Gilbert M; Brochu D; St Michael F; Li J; Wakarchuk WW; Goodhead I; Sanders M; Stevens K; White B; Parkhill J; Wren BW; Szymanski CM
Mol Microbiol; 2005 Jan; 55(1):90-103. PubMed ID: 15612919
[TBL] [Abstract][Full Text] [Related]
39. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?
Jung S; Zimmer S; Lüneberg E; Frosch M; Karch H; Korn T; Toyka KV
Neurosci Lett; 2005 Jun 10-17; 381(1-2):175-8. PubMed ID: 15882812
[TBL] [Abstract][Full Text] [Related]
40. Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations.
Parker CT; Gilbert M; Yuki N; Endtz HP; Mandrell RE
J Bacteriol; 2008 Aug; 190(16):5681-9. PubMed ID: 18556784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
